Insmed Incorporated
INSM
$64.97
-$3.12-4.58%
| Weiss Ratings | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.69% | |||
| 30-Day Total Return | -16.17% | |||
| 60-Day Total Return | -0.43% | |||
| 90-Day Total Return | -12.31% | |||
| Year to Date Total Return | -7.12% | |||
| 1-Year Total Return | 131.13% | |||
| 2-Year Total Return | 286.96% | |||
| 3-Year Total Return | 162.72% | |||
| 5-Year Total Return | 254.06% | |||
| 52-Week High % Change | -19.81% | |||
| 52-Week Low % Change | 210.63% | |||
| Price | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $84.91 | |||
| 52-Week Low Price | $21.92 | |||
| 52-Week Low Price (Date) | May 24, 2024 | |||
| 52-Week High Price (Date) | Feb 21, 2025 | |||
| Valuation | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 12.32B | |||
| Enterprise Value | 12.20B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -5.59 | |||
| Earnings Per Share Growth | 4.49% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 33.52 | |||
| Price/Book (Q) | 42.80 | |||
| Enterprise Value/Revenue (TTM) | 33.54 | |||
| Price | $64.97 | |||
| Enterprise Value/EBITDA (TTM) | -15.69 | |||
| Enterprise Value/EBIT | -15.51 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 179.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 908 977 9900 | |||
| Address | 700 US Highway 202/206 Bridgewater, NJ 08807 | |||
| Website | www.insmed.com | |||
| Country | United States | |||
| Year Founded | 1988 | |||
| Profitability | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -216.26% | |||
| Profit Margin | -251.23% | |||
| Management Effectiveness | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -29.31% | |||
| Return on Equity | -- | |||
| Income Statement | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 363.71M | |||
| Total Revenue (TTM) | 363.71M | |||
| Revenue Per Share | $2.03 | |||
| Gross Profit (TTM) | 277.97M | |||
| EBITDA (TTM) | -777.70M | |||
| EBIT (TTM) | -786.57M | |||
| Net Income (TTM) | -913.77M | |||
| Net Income Avl. to Common (TTM) | -913.77M | |||
| Total Revenue Growth (Q YOY) | 24.79% | |||
| Earnings Growth (Q YOY) | -26.60% | |||
| EPS Diluted (TTM) | -5.59 | |||
| EPS Diluted Growth (Q YOY) | -2.40% | |||
| Balance Sheet | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.43B | |||
| Cash Per Share (Q) | $8.01 | |||
| Total Current Assets (Q) | 1.62B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 285.38M | |||
| Current Ratio (Q) | 5.450 | |||
| Book Value Per Share (Q) | $1.59 | |||
| Total Assets (Q) | 2.03B | |||
| Total Current Liabilities (Q) | 297.53M | |||
| Total Debt (Q) | 1.31B | |||
| Total Liabilities (Q) | 1.74B | |||
| Total Common Equity (Q) | 285.38M | |||
| Cash Flow | INSM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -583.18M | |||
| Cash from Financing (TTM) | 1.34B | |||
| Net Change in Cash (TTM) | 72.66M | |||
| Levered Free Cash Flow (TTM) | -418.30M | |||
| Cash from Operations (TTM) | -683.88M | |||
